|
JPS552601A
(en)
|
1978-06-20 |
1980-01-10 |
Yamasa Shoyu Co Ltd |
Anti-tumor agent for non-injection use
|
|
US5674998A
(en)
|
1989-09-15 |
1997-10-07 |
Gensia Inc. |
C-4' modified adenosine kinase inhibitors
|
|
US6110901A
(en)
*
|
1990-07-03 |
2000-08-29 |
American Cyanamid Company |
Method for treating RNA viral infections by using RNA chain terminators
|
|
US5432272A
(en)
|
1990-10-09 |
1995-07-11 |
Benner; Steven A. |
Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
|
|
JPH07242544A
(ja)
|
1994-03-01 |
1995-09-19 |
Takeda Chem Ind Ltd |
抗腫瘍剤
|
|
PL187439B1
(pl)
|
1996-01-23 |
2004-07-30 |
Icn Pharmaceuticals |
Zastosowanie rybawiryny
|
|
BR9714349A
(pt)
|
1996-10-16 |
2000-11-14 |
Icn Pharmaceuticals |
L-nucleosìdeos purina, seus análogos e utilizacões dos mesmos
|
|
ATE238328T1
(de)
|
1996-10-16 |
2003-05-15 |
Ribapharm Inc |
Monozyklische l-nukleoside, analoga und ihre anwendungen
|
|
US20030064945A1
(en)
|
1997-01-31 |
2003-04-03 |
Saghir Akhtar |
Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors
|
|
WO1999061583A2
(en)
|
1998-05-28 |
1999-12-02 |
Incara Pharmaceuticals Corp. |
Carbohydrate-based scaffold compounds, combinatorial libraries and methods for their construction
|
|
DE19855963A1
(de)
|
1998-12-04 |
2000-06-08 |
Herbert Schott |
Amphiphile Glycerylnucleotide, Verfahren zu ihrer Herstellung und ihre Verwendung
|
|
ATE250622T1
(de)
|
1999-05-12 |
2003-10-15 |
Yamasa Corp |
4'-c-ethynyl-pyrimidine nukleoside
|
|
US6495677B1
(en)
|
2000-02-15 |
2002-12-17 |
Kanda S. Ramasamy |
Nucleoside compounds
|
|
US6815542B2
(en)
|
2000-06-16 |
2004-11-09 |
Ribapharm, Inc. |
Nucleoside compounds and uses thereof
|
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
|
SK286630B6
(sk)
|
2001-01-22 |
2009-02-05 |
Merck & Co., Inc. |
Nukleozidové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
|
|
US7105499B2
(en)
|
2001-01-22 |
2006-09-12 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
|
WO2003070912A2
(en)
|
2001-06-06 |
2003-08-28 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
US20030175950A1
(en)
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
|
WO2002097114A2
(en)
|
2001-05-29 |
2002-12-05 |
Sirna Therapeutics, Inc. |
Nucleic acid treatment of diseases or conditions related to levels of ras, her2 and hiv
|
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
|
US6962991B2
(en)
|
2001-09-12 |
2005-11-08 |
Epoch Biosciences, Inc. |
Process for the synthesis of pyrazolopyrimidines
|
|
US20040006002A1
(en)
|
2001-09-28 |
2004-01-08 |
Jean-Pierre Sommadossi |
Methods and compositions for treating flaviviruses and pestiviruses using 4'-modified nucleoside
|
|
EP1435974A4
(en)
|
2001-09-28 |
2006-09-06 |
Idenix Cayman Ltd |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATITIS C VIRUS USING 4 'MODIFIED NUCLEOSIDES
|
|
WO2003039523A2
(en)
|
2001-11-05 |
2003-05-15 |
Exiqon A/S |
OLIGONUCLEOTIDES MODIFIED WITH NOVEL α-L-RNA ANALOGUES
|
|
US7125982B1
(en)
|
2001-12-05 |
2006-10-24 |
Frayne Consultants |
Microbial production of nuclease resistant DNA, RNA, and oligo mixtures
|
|
WO2003062256A1
(en)
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents
|
|
EP1572705A2
(en)
|
2002-01-17 |
2005-09-14 |
Ribapharm, Inc. |
Sugar modified nucleosides as viral replication inhibitors
|
|
JP2005527499A
(ja)
|
2002-02-13 |
2005-09-15 |
メルク エンド カムパニー インコーポレーテッド |
ヌクレオシド化合物を用いてオルトポックスウイルスの複製を阻害する方法
|
|
JP2005524662A
(ja)
|
2002-02-28 |
2005-08-18 |
ビオタ インコーポレーティッド |
ヌクレオシド５’−一リン酸模倣物およびこれらのプロドラッグ
|
|
WO2003099840A1
(en)
|
2002-05-24 |
2003-12-04 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having modified nucleoside units
|
|
AU2003241621A1
(en)
|
2002-05-24 |
2003-12-12 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having modified nucleoside units
|
|
WO2004000858A2
(en)
|
2002-06-21 |
2003-12-31 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
|
EP1572945A2
(en)
|
2002-06-27 |
2005-09-14 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
|
PL374792A1
(en)
|
2002-06-28 |
2005-10-31 |
Idenix (Cayman) Limited |
2' and 3'-nucleoside prodrugs for treating flaviviridae infections
|
|
TW200500375A
(en)
|
2002-06-28 |
2005-01-01 |
Idenix Cayman Ltd |
Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae
|
|
EP1556399A4
(en)
|
2002-07-16 |
2007-09-26 |
Merck & Co Inc |
Nucleoside derivatives as inhibitors of RNA-dependent viral RNA polymerase
|
|
WO2004014312A2
(en)
|
2002-08-08 |
2004-02-19 |
Sirna Therapeutics, Inc. |
Small-mer compositions and methods of use
|
|
WO2004037159A2
(en)
|
2002-10-23 |
2004-05-06 |
Obetherapy Biotechnology |
Compounds, compositions and methods for modulating fat metabolism
|
|
US20040229840A1
(en)
*
|
2002-10-29 |
2004-11-18 |
Balkrishen Bhat |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
|
US7393954B2
(en)
|
2002-12-12 |
2008-07-01 |
Reliable Biopharmaceutical Corporation |
Process for the production of pentostatin aglycone and pentostatin
|
|
WO2004080466A1
(en)
|
2003-03-07 |
2004-09-23 |
Ribapharm Inc. |
Cytidine analogs and methods of use
|
|
EP1613261A4
(en)
|
2003-04-09 |
2011-01-26 |
Novo Nordisk As |
INTRA-CELLULAR FORMATION OF PEPTIDE CONJUGATES
|
|
US20040259934A1
(en)
|
2003-05-01 |
2004-12-23 |
Olsen David B. |
Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
|
|
EP1656093A2
(en)
|
2003-05-14 |
2006-05-17 |
Idenix (Cayman) Limited |
Nucleosides for treatment of infection by corona viruses, toga viruses and picorna viruses
|
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
|
WO2005020885A2
(en)
|
2003-05-21 |
2005-03-10 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
|
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
|
HUE029877T2
(en)
*
|
2003-05-30 |
2017-04-28 |
Gilead Pharmasset Llc |
Modified fluorinated nucleoside analogues
|
|
EP1644479A4
(en)
|
2003-06-16 |
2008-04-23 |
Mark W Grinstaff |
FUNCTIONAL SYNTHETIC MOLECULES AND MACROMOLECULES FOR GENERAL FEEDING
|
|
US20050075309A1
(en)
|
2003-07-25 |
2005-04-07 |
Richard Storer |
Purine nucleoside analogues for treating Flaviviridae including hepatitis C
|
|
NZ546055A
(en)
|
2003-08-27 |
2010-05-28 |
Biota Scient Management |
Novel tricyclic nucleosides or nucleotides as therapeutic agents
|
|
WO2006033709A2
(en)
*
|
2004-07-29 |
2006-03-30 |
Metabasis Therapeutics, Inc. |
Novel nucleoside derivatives
|
|
CA2571675A1
(en)
|
2004-06-23 |
2006-01-05 |
Idenix (Cayman) Limited |
5-aza-7-deazapurine derivatives for treating infections with flaviviridae
|
|
WO2006063717A2
(en)
|
2004-12-16 |
2006-06-22 |
Febit Biotech Gmbh |
Polymerase-independent analysis of the sequence of polynucleotides
|
|
US7524831B2
(en)
*
|
2005-03-02 |
2009-04-28 |
Schering Corporation |
Treatments for Flaviviridae virus infection
|
|
CA2600886A1
(en)
|
2005-03-08 |
2006-09-14 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
|
JP2008535932A
(ja)
|
2005-03-09 |
2008-09-04 |
イデニクス（ケイマン）リミテツド |
抗ウィルス剤としての非天然塩基を有するヌクレオシド
|
|
EP2805719A1
(en)
|
2005-03-30 |
2014-11-26 |
Glaxosmithkline LLC |
Nicotinamide riboside and analogues thereof
|
|
US8207136B2
(en)
|
2005-04-26 |
2012-06-26 |
The Board Of Trustees Of The University Of Illinois |
Nucleoside compounds and methods of use thereof
|
|
WO2007020018A1
(en)
|
2005-08-12 |
2007-02-22 |
Universite Libre De Bruxelles |
Use of purinergic and pyrimidinergic receptor agonists for dendritic cells based immunotherapies
|
|
WO2007020193A2
(en)
|
2005-08-15 |
2007-02-22 |
F. Hoffmann-La Roche Ag |
Antiviral phosphoramidates of 4 ' -substituted pronucleotides
|
|
EA200800932A1
(ru)
|
2005-09-26 |
2008-10-30 |
Фармассет, Инк. |
Модифицированные 4`-нуклеозиды в качестве противовирусных агентов
|
|
US20090118220A1
(en)
|
2006-04-03 |
2009-05-07 |
Astrazeneca Ab |
Substituted adenines and the uses thereof
|
|
GB0614947D0
(en)
|
2006-07-27 |
2006-09-06 |
Isis Innovation |
Epitope reduction therapy
|
|
US20080261913A1
(en)
|
2006-12-28 |
2008-10-23 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of liver disorders
|
|
JP2010515680A
(ja)
|
2007-01-05 |
2010-05-13 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Ｒｎａ依存性ｒｎａウイルス感染症の治療用としてのヌクレオシドアリールホスホロアミデート
|
|
MX2009007333A
(es)
|
2007-01-12 |
2009-08-31 |
Biocryst Pharm Inc |
Analogos de nucleosidos antivirales.
|
|
US20120135091A1
(en)
|
2007-01-18 |
2012-05-31 |
Roth Mark B |
Methods and compositions for enhancing lifespan involving sirtuin-modulating compounds and chalcogenides
|
|
CA2676822A1
(en)
|
2007-01-31 |
2008-08-07 |
Alios Biopharma, Inc. |
2-5a analogs and their methods of use
|
|
JP2008214305A
(ja)
|
2007-03-07 |
2008-09-18 |
Kotobuki Seiyaku Kk |
置換アミン誘導体及びこれを有効成分とする医薬組成物
|
|
EP2136626A4
(en)
|
2007-03-19 |
2011-02-23 |
Oregon State |
Mannich base n-oxide drugs
|
|
WO2008117047A1
(en)
|
2007-03-27 |
2008-10-02 |
Astrazeneca Ab |
Pyrazolo[3, 4-d]pyrimidine derivatives as antibacterial compounds
|
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
|
WO2008127613A1
(en)
|
2007-04-11 |
2008-10-23 |
Scynexis, Inc. |
New pharmaceutical compositions
|
|
EP1980568A1
(de)
|
2007-04-13 |
2008-10-15 |
Eberhard Karls Universität Tübingen |
Ethinylierte Heterodinucleosidphosphatanaloga, Verfahren zu deren Herstellung und deren Verwendung
|
|
DK2014771T3
(en)
|
2007-06-25 |
2015-03-09 |
Anadys Pharmaceuticals Inc |
Continuous process for the enzymatic hydrolysis
|
|
GB0712494D0
(en)
|
2007-06-27 |
2007-08-08 |
Isis Innovation |
Substrate reduction therapy
|
|
GB0718575D0
(en)
|
2007-09-24 |
2007-10-31 |
Angeletti P Ist Richerche Bio |
Nucleoside derivatives as inhibitors of viral polymerases
|
|
US20090318380A1
(en)
|
2007-11-20 |
2009-12-24 |
Pharmasset, Inc. |
2',4'-substituted nucleosides as antiviral agents
|
|
MX2010005752A
(es)
|
2007-12-07 |
2010-06-15 |
Hoffmann La Roche |
Vectores transportadores del replicon de proteasa ns3 del virus de la hepatitis c.
|
|
US20090176732A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma Inc. |
Protected nucleotide analogs
|
|
WO2009086201A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma, Inc. |
2-5a analogs and their use as anti-cancer, anti-viral and anti- paras iti c agents
|
|
EA018551B1
(ru)
|
2008-02-22 |
2013-08-30 |
Айрм Ллк |
ГЕТЕРОЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ И СОДЕРЖАЩИЕ ИХ КОМПОЗИЦИИ В КАЧЕСТВЕ ИНГИБИТОРОВ КИНАЗ c-KIT И PDGFR
|
|
MX2010010272A
(es)
|
2008-03-19 |
2011-05-25 |
Chembridge Corp |
Nuevos inhibidores de tirosina quinasa.
|
|
WO2009129120A2
(en)
|
2008-04-15 |
2009-10-22 |
Rfs Pharma, Llc |
Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
|
|
WO2010036407A2
(en)
|
2008-05-15 |
2010-04-01 |
Biocryst Pharmaceuticals, Inc. |
Antiviral nucleoside analogs
|
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
|
AR072906A1
(es)
|
2008-08-06 |
2010-09-29 |
Novartis Ag |
Nucleosidos modificados utiles como antivirales
|
|
GB0815968D0
(en)
|
2008-09-03 |
2008-10-08 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
|
JPWO2010027005A1
(ja)
|
2008-09-05 |
2012-02-02 |
壽製薬株式会社 |
置換アミン誘導体及びこれを有効成分とする医薬組成物
|
|
US8163707B2
(en)
|
2008-09-15 |
2012-04-24 |
Enanta Pharmaceuticals, Inc. |
4′-allene-substituted nucleoside derivatives
|
|
US20100099079A1
(en)
|
2008-09-26 |
2010-04-22 |
Uprichard Susan L |
Non-dividing cell-based assay for high throughput antiviral compound screening
|
|
AU2009329872B2
(en)
*
|
2008-12-23 |
2016-07-07 |
Gilead Pharmasset Llc |
Synthesis of purine nucleosides
|
|
EP2393815A4
(en)
|
2009-02-06 |
2012-11-21 |
Rfs Pharma Llc |
PURIN NUCLEOSIDE MONOPHOSPHATE PRODRUGS FOR THE TREATMENT OF CANCER AND VIRUS INFECTIONS
|
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
|
WO2010108135A1
(en)
|
2009-03-20 |
2010-09-23 |
Alios Biopharma, Inc. |
Protected nucleotide analogs
|
|
JP2012521359A
(ja)
|
2009-03-20 |
2012-09-13 |
アリオス バイオファーマ インク． |
置換されたヌクレオシドアナログおよびヌクレオチドアナログ
|
|
LT3009428T
(lt)
|
2009-05-08 |
2018-04-10 |
Astellas Pharma Inc. |
Diamino heterociklinis karboksamido junginys
|
|
EP2264169A1
(en)
|
2009-06-15 |
2010-12-22 |
Qiagen GmbH |
Modified siNA
|
|
WO2011005595A2
(en)
|
2009-06-24 |
2011-01-13 |
Alios Biopharma, Inc. |
2-5a analogs and their methods of use
|
|
WO2011005860A2
(en)
|
2009-07-07 |
2011-01-13 |
Alnylam Pharmaceuticals, Inc. |
5' phosphate mimics
|
|
WO2011057204A2
(en)
|
2009-11-06 |
2011-05-12 |
The Johns Hopkins University |
Lrrk2-mediated neuronal toxicity
|
|
WO2011133871A2
(en)
|
2010-04-22 |
2011-10-27 |
Alnylam Pharmaceuticals, Inc. |
5'-end derivatives
|
|
AU2011282241B2
(en)
|
2010-07-19 |
2015-07-30 |
Gilead Sciences, Inc. |
Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
|
|
EP2619215B1
(en)
|
2010-09-22 |
2018-09-05 |
Alios Biopharma, Inc. |
Azido nucleosides and nucleotide analogs
|
|
WO2012040126A1
(en)
|
2010-09-22 |
2012-03-29 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
|
NZ607996A
(en)
|
2010-09-22 |
2014-07-25 |
Alios Biopharma Inc |
Substituted nucleotide analogs
|
|
AR083221A1
(es)
|
2010-09-29 |
2013-02-06 |
Univ Nac Quilmes |
Proceso para producir dialquilfosfotriesteres de nucleosidos mediante transesterificacion enzimatica y desproteccion de los mismos para producir nucleosidos monofosfato
|
|
CN102516339B
(zh)
|
2010-10-21 |
2014-03-19 |
四川大学华西医院 |
嘧啶并嘧啶化合物及其核苷类似衍生物和制备方法及用途
|
|
WO2012074547A2
(en)
|
2010-11-29 |
2012-06-07 |
New York University |
STEROID COMPOUNDS AS RORγt MODULATORS AND USES THEREOF
|
|
CA2819041A1
(en)
|
2010-12-22 |
2012-06-28 |
Alios Biopharma, Inc. |
Cyclic nucleotide analogs
|
|
US9095599B2
(en)
|
2011-01-03 |
2015-08-04 |
Nanjing Molecular Research, Inc. |
O-(substituted benzyl) phosphoramidate compounds and therapeutic use
|
|
BR112013026345A2
(pt)
|
2011-04-13 |
2019-04-24 |
Merck Sharp & Dohe Corp. |
composto, composição farmacêutica, uso de um composto, e, método para tratar um paciente infectado com hcv
|
|
US8877733B2
(en)
|
2011-04-13 |
2014-11-04 |
Gilead Sciences, Inc. |
1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment
|
|
WO2013019874A1
(en)
|
2011-08-01 |
2013-02-07 |
Mbc Pharma, Inc. |
Vitamin b6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates
|
|
CN102408411B
(zh)
|
2011-09-19 |
2014-10-22 |
北京康辰药业股份有限公司 |
一种含喹啉基的羟肟酸类化合物及其制备方法、以及含有该化合物的药物组合物及其应用
|
|
WO2013044030A1
(en)
|
2011-09-23 |
2013-03-28 |
Enanta Pharmaceuticals, Inc. |
2'-chloroacetylenyl substituted nucleoside derivatives
|
|
AU2012357940B2
(en)
*
|
2011-12-20 |
2017-02-16 |
Riboscience Llc |
2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
|
|
CA2860234A1
(en)
*
|
2011-12-22 |
2013-06-27 |
Alios Biopharma, Inc. |
Substituted phosphorothioate nucleotide analogs
|
|
SG10201913554YA
(en)
|
2011-12-22 |
2020-03-30 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
|
HK1206362A1
(zh)
|
2012-03-21 |
2016-01-08 |
Alios Biopharma, Inc. |
硫代氨基磷酸酯核苷酸前藥的固體形式
|
|
WO2013142159A1
(en)
*
|
2012-03-21 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
US8846896B2
(en)
|
2012-03-21 |
2014-09-30 |
Alios Biopharma, Inc. |
Methods of preparing substituted nucleotide analogs
|
|
GEP201706721B
(en)
*
|
2012-03-21 |
2017-08-25 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
|
WO2013142157A1
(en)
*
|
2012-03-22 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
|
CN102816197B
(zh)
|
2012-08-24 |
2015-04-29 |
四川大学华西医院 |
一种新的嘧啶并嘧啶类核苷类似物、制备方法及其形成的超分子结构和应用
|
|
HK1214270A1
(zh)
|
2012-10-29 |
2016-07-22 |
共晶制药股份有限公司 |
用於治療病毒感染和癌症的嘧啶核苷及其單磷酸酯前藥
|
|
EP2935304A1
(en)
*
|
2012-12-19 |
2015-10-28 |
IDENIX Pharmaceuticals, Inc. |
4'-fluoro nucleosides for the treatment of hcv
|
|
BR112015014457A2
(pt)
*
|
2012-12-21 |
2017-11-21 |
Alios Biopharma Inc |
composto ou sal farmaceuticamente aceitável do mesmo e composição farmacêutica e respectivos usos e processos para melhorar ou tratar infecção de hcv, para inibir a atividade da ns5b polimerase do vírus da hepatite c e a replicação de vírus da hepatite c
|
|
US9598457B2
(en)
|
2012-12-21 |
2017-03-21 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
WO2014134251A1
(en)
|
2013-02-28 |
2014-09-04 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions
|
|
WO2014164533A1
(en)
|
2013-03-11 |
2014-10-09 |
Vertex Pharmaceuticals Incorporated |
Methods of stereoselective synthesis of substituted nucleoside analogs
|
|
CA2908313A1
(en)
|
2013-04-05 |
2014-10-09 |
Alios Biopharma, Inc. |
Hepatitis c viral infection treatment using a combination of compounds
|
|
JP6366693B2
(ja)
|
2013-05-16 |
2018-08-01 |
リボサイエンス・エルエルシー |
４’−フルオロ−２’−メチル置換ヌクレオシド誘導体
|
|
MX2015017556A
(es)
|
2013-06-26 |
2016-05-09 |
Alios Biopharma Inc |
Nucleosidos sustituidos, nucleotidos y analogos de los mismos.
|
|
AU2014302711A1
(en)
*
|
2013-06-26 |
2015-12-10 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
WO2015054465A1
(en)
|
2013-10-11 |
2015-04-16 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
HUE051986T2
(hu)
|
2014-06-24 |
2021-04-28 |
Janssen Biopharma Inc |
Helyettesített nukleozidok, nukleotidek és analógjaik virális fertõzés kezelésére való alkalmazásra
|
|
AU2015280245A1
(en)
|
2014-06-24 |
2017-01-05 |
Alios Biopharma, Inc. |
Methods of preparing substituted nucleotide analogs
|
|
MA40031A
(fr)
|
2014-06-24 |
2015-12-30 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
|
CA2955604A1
(en)
|
2014-07-22 |
2016-01-28 |
Alios Biopharma, Inc. |
Methods for treating paramyxoviruses
|
|
PE20170673A1
(es)
|
2014-08-05 |
2017-05-22 |
Alios Biopharma Inc |
Terapia de combinacion para tratar una paramixovirus
|
|
WO2016069489A1
(en)
|
2014-10-28 |
2016-05-06 |
Alios Biopharma, Inc. |
Methods of preparing substituted nucleoside analogs
|
|
MA41213A
(fr)
|
2014-12-19 |
2017-10-24 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
|
MA41441A
(fr)
|
2014-12-19 |
2017-12-12 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
|
TW201811339A
(zh)
|
2016-08-12 |
2018-04-01 |
美商艾洛斯生物製藥公司 |
經取代之核苷、核苷酸及其類似物
|
|
US20180117042A1
(en)
|
2016-10-27 |
2018-05-03 |
Alios Biopharma, Inc. |
Methods for treating respiratory syncytial virus infection
|